Suppliers / Koye Pharmaceuticals

Koye Pharmaceuticals

India 719 employees Updated 9 July 2026

Koye Pharmaceuticals is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $110K of exports covering 1 molecule to 1 destination in 2022.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Albendazole US FDA 1

Also appears on these molecule pages

Albendazole API

Scale

Year Revenue Exports Destinations
2022 Not reported $110K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Koye Pharmaceuticals

Does Koye Pharmaceuticals hold a US DMF or a CEP?
Koye Pharmaceuticals holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Koye Pharmaceuticals make?
1 molecule is on record against Koye Pharmaceuticals, including Albendazole. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Koye Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Cipla shares 1 molecule Zydus Lifesciences shares 1 molecule Solara Active Pharma Sciences shares 1 molecule Unimark Remedies shares 1 molecule Alivira Animal Health shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts